World Cancer Day 2016
IDA Foundation product range aims to improve access to affordable quality cancer treatment and palliative care
World Cancer Day – 4th of February - aims to save millions of preventable deaths each year by raising awareness and education about cancer, and pressing governments and individuals across the world to take action against the disease. IDA Foundation, as a member of the Union for International Cancer Control (UICC), joins the many initiatives around the world in this mission.
Cancer has reached epidemic proportions worldwide. Today, it kills more people than HIV/AIDS, TB and Malaria combined. Closing the gap in access to affordable, quality cancer care is an imperative for maximising outcomes and quality of life for all people living with cancer, including children and adolescents. While prevention and early detection are critical, we believe that affordable, quality assured treatment options can save many lives. And although cancer treatment is complex, as it may require surgery, radiation and chemo-hormonal therapy, medicines are already available for a number of priority cancers.
Sadly, cancer treatment is often too expensive and not accessible for many. IDA Foundation would like to make cancer medication more affordable and accessible in low- and middle-income countries as part of the other NCD medicines we supply. In the past, HIV/AIDS and TB treatments were unavailable to many. By pooling procurement of cancer medicines, customers needing small amounts of medicines are able to buy from us, thereby avoiding the high minimum order quantities that manufacturers require. We are keeping stock of high priority products for treatment of the most common forms of cancer, thereby bringing treatment within reach for more patients in low- and middle-income countries.
In addition to cancer treatment, palliative care, including access to pain relief, is an urgent humanitarian need worldwide for children and adults with advanced cancers. Current estimates suggest that at least 2.9 million cancer and HIV/AIDS patients suffer the terminal phase of their disease with no pain relief. We have included palliative medicines in our oncology product list, which is still in development. Are you in need of products not listed here? Send your feedback on product needs to us (Marieke Korsten – email@example.com)!
More information on our oncology and palliative care activities: